Increasing evidence indicates that cationic liposomes are capable of s
afely transferring foreign genes to pulmonary epithelium in vitro and
in vivo. To transfer reporter genes and the cystic fibrosis transmembr
ane conductance regulator(CFTR) to mammalian respiratory epithelium we
used two cationic lipid formulations: N-[1-(2,3-dioleoyloxy)propyl] N
,N,N-triethylammonium chloride (DOTMA), and imyristyloxy-propyl-3-dime
thylhydroxyethylammonium bromide (DMRIE) at a 1:1 molar ratio with dio
leoyl phosphatidylethanolamine (DOPE). Lipid-DNA conjugates containing
either CFTR or LacZ were instilled directly into the airways of Sprag
ue-Dawley rats. Rats treated with LacZ cDNA in vivo demonstrated expre
ssion in 30-50% of the large and medium-sized airways with some airway
s showing high efficiency gene transfer and expression (in the most pr
oximal airways, 70-80% of surface epithelial cells were positive for e
xpression of a nuclear targeted LacZ). While control and LacZ treated
tracheas mounted in Ussing chambers showed minimal stimulation of tran
sepithelial chloride (Cl-) currents by cAMP (suggesting low levels of
endogenous fat CFTR activity), tracheas taken from animals receiving C
FTR exhibited significant forskolin-stimulated currents at 72 h after
gene transfer Human CFTR gene expression was also detected by polymera
se chain reaction (PCR) analysis of reverse transcribed lung RNA. Thes
e results, together with previous studies using lipid-mediated gene tr
ansfer in mice, help confirm the potential for cationic lipid-mediated
gene transfer in the gene therapy of cystic fibrosis in humans.